In:
Journal of the Pediatric Infectious Diseases Society, Oxford University Press (OUP), Vol. 9, No. 2 ( 2020-04-30), p. 253-256
Abstract:
Of 56 children with perinatally acquired human immunodeficiency virus (HIV) who had been prescribed second-line protease inhibitor–based antiretroviral therapy and had ≥1 previous episode of viral failure (HIV RNA, ≥1000 copies/mL), 46% had ≥1, 34% had ≥2, and 23% had ≥3 consecutive episodes of viral failure during the 2 years of follow-up. Two of these children experienced a major protease inhibitor mutation.
Type of Medium:
Online Resource
ISSN:
2048-7207
DOI:
10.1093/jpids/piz034
Language:
English
Publisher:
Oxford University Press (OUP)
Publication Date:
2020
detail.hit.zdb_id:
2668791-4